Omnicare, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Omnicare, Inc. - overview
Established
2002
Location
Cincinnati, OH, US
Primary Industry
Pharmaceuticals
About
Omnicare, Inc. is a provider of pharmacy solutions tailored for long-term and post-acute care facilities, ensuring efficient medication management and compliance within healthcare environments. Established in 2002, Omnicare, Inc. is headquartered in Cincinnati, US.
The company specializes in pharmacy services for long-term care settings. In August 2019, Equistone Partners Europe acquired a majority stake in the company, completing the transaction in October 2019. The current CEO is Aieshery Ali, S. Ford.
Omnicare specializes in providing comprehensive pharmacy solutions tailored specifically for long-term and post-acute care facilities. Their core offerings include advanced pharmacy management services, clinical pharmacy consulting, predictive refill programs, and specialized packaging that enhances medication delivery efficiency. These solutions are designed to meet the specific needs of skilled nursing facilities, assisted living communities, mental health centers, and hospice care. By utilizing proprietary digital tools and 24/7 clinical support, Omnicare ensures correct and timely medication administration in compliance with relevant regulations.
Their products and services are available across 47 states in the United States, serving a diverse client base that includes healthcare providers, facilities, residents, and their families. In the most recent year, Omnicare reported a revenue of USD 755. 76 mn. The company generates revenue through B2B partnerships with long-term care facilities and healthcare providers, engaging in contracts for medication management, clinical oversight, and specialized delivery systems.
Their pricing reflects the tailored services offered, including clinical pharmacy consulting and transition of care services. Omnicare plans to enhance its service offerings by launching new products and expanding into additional geographic regions. The company aims to further develop its pharmacy management solutions, although specific product launch dates have not been disclosed. The recent acquisition by Equistone Partners Europe in October 2019 is expected to provide the necessary capital to support these growth initiatives, allowing for continued expansion into new markets and enhancement of existing service lines.
Current Investors
Equistone Partners Europe
Primary Industry
Pharmaceuticals
Sub Industries
Healthcare, Oncology/Cancer Treatment, Pharmaceuticals
Website
www.omnicare.com
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Omnicare, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Omnicare, Inc. | - | ||||||||
| Add-on | Completed | Tidewater Group | - | ||||||||
| Buyout | Completed | Theorem Clinical Research | - | ||||||||
| Trade Sale | Completed | Continuing Care Rx | - | ||||||||
| Trade Sale | Completed | ExcelleRx, Inc. | - |
Displaying 1 - 5 of 6

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.